Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients
1984; Oxford University Press; Volume: 14; Issue: 1 Linguagem: Inglês
10.1093/jac/14.1.81
ISSN1460-2091
AutoresDonald P. Reitberg, Thomas J. Cumbo, Jerome J. Schentag,
Tópico(s)Drug-Induced Adverse Reactions
ResumoJournal Article Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients Get access Donald P. Reitberg, Donald P. Reitberg *Department of Pharmaceutics and the Division of Clinical Pharmacy Sciences, State University of New YorkBuffalo†Clinical Pharmacokinetics Laboratory, Millard Fillmore HospitalBuffalo, New York 14209, U.S.A. Jerome J. Schentag, Pharm. D, Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, New York 14209, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar Thomas J. Cumbo, Thomas J. Cumbo ‡Department of Medicine, Millard Fillmore HospitalBuffalo, New York 14209, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar Jerome J. Schentag Jerome J. Schentag *Department of Pharmaceutics and the Division of Clinical Pharmacy Sciences, State University of New YorkBuffalo†Clinical Pharmacokinetics Laboratory, Millard Fillmore HospitalBuffalo, New York 14209, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar Journal of Antimicrobial Chemotherapy, Volume 14, Issue 1, July 1984, Pages 81–91, https://doi.org/10.1093/jac/14.1.81 Published: 01 July 1984 Article history Accepted: 10 November 1983 Published: 01 July 1984
Referência(s)